Single-cell transcriptomic analysis to identify endomembrane regulation of metalloproteins and motor proteins in autoimmunity.

Antigen processing cells Autoimmunity Dendritic cells Endothelial cells Giant cell arteritis (GCA) Glycans Glycobiology Golgi complex Lysosomes Metalloproteinases Metalloproteins Mitochondria Motor proteins Natural killer cells Phagocytes Phagosomes RNASET2 Transmembrane TMEM230 Vasculitis, Rheumatoid arthritis

Journal

Advances in protein chemistry and structural biology
ISSN: 1876-1631
Titre abrégé: Adv Protein Chem Struct Biol
Pays: Netherlands
ID NLM: 101497281

Informations de publication

Date de publication:
2024
Historique:
medline: 4 7 2024
pubmed: 4 7 2024
entrez: 3 7 2024
Statut: ppublish

Résumé

TMEM230 promotes antigen processing, trafficking, and presentation by regulating the endomembrane system of membrane bound organelles (lysosomes, proteosomes and mitochondria) and phagosomes. Activation of the immune system requires trafficking of various cargos between the endomembrane system and cell plasma membrane. The Golgi apparatus is the hub of the endomembrane system and essential for the generation, maintenance, recycling, and trafficking of the components of the endomembrane system itself and immune system. Intracellular trafficking and secretion of immune system components depend on mitochondrial metalloproteins for ATP synthesis that powers motor protein transport of endomembrane cargo. Glycan modifying enzyme genes and motor proteins are essential for the activation of the immune system and trafficking of antigens between the endomembrane system and the plasma membrane. Recently, TMEM230 was identified as co-regulated with RNASET2 in lysosomes and with metalloproteins in various cell types and organelles, including mitochondria in autoimmune diseases. Aberrant metalloproteinase secretion by motor proteins is a major contributor to tissue remodeling of synovial membrane and joint tissue destruction in rheumatoid arthritis (RA) by promoting infiltration of blood vessels, bone erosion, and loss of cartilage by phagocytes. In this study, we identified that specific glycan processing enzymes are upregulated in certain cell types (fibroblast or endothelial cells) that function in destructive tissue remodeling in rheumatoid arthritis compared to osteoarthritis (OA). TMEM230 was identified as a regulator in the secretion of metaloproteinases and heparanase necessary tissue remodeling in OA and RA. In dendritic (DC), natural killer and T cells, TMEM230 was expressed at low or no levels in RA compared to OA. TMEM230 expression in DC likely is necessary for regulatory or helper T cells to maintain tolerance to self-antigens and prevent susceptibility to autoimmune disease. To identify how TMEM230 and the endomembrane system contribute to autoimmunity we investigated, glycan modifying enzymes, metalloproteinases and motor protein genes co-regulated with or regulated by TMEM230 in synovial tissue by analyzing published single cell transcriptomic datasets from RA patient derived synovial tissue.

Identifiants

pubmed: 38960478
pii: S1876-1623(24)00033-6
doi: 10.1016/bs.apcsb.2024.03.007
pii:
doi:

Substances chimiques

Metalloproteins 0
Membrane Proteins 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

299-329

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Edoardo Abeni (E)

Institute of Biomedical Technologies, National Research Council, Milan, Italy.

Cinzia Cocola (C)

Institute of Biomedical Technologies, National Research Council, Milan, Italy.

Stefania Croci (S)

Clinical Immunology, Allergy and Advanced Biotechnologies, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy.

Valentina Martino (V)

Institute of Biomedical Technologies, National Research Council, Milan, Italy.

Eleonora Piscitelli (E)

Institute of Biomedical Technologies, National Research Council, Milan, Italy.

Roberta Gualtierotti (R)

Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Paride Pelucchi (P)

Institute of Biomedical Technologies, National Research Council, Milan, Italy.

Valeria Tria (V)

Institute of Biomedical Technologies, National Research Council, Milan, Italy.

Giovanni Porta (G)

Centro di Medicina Genomica Department of Medicine and Surgery, University of Insubria, Varese, Italy.

Fabian Troschel (F)

Department of Radiation Therapy and Radiation Oncology, University Hospital of Münster, Münster, Germany.

Burkhard Greve (B)

Department of Radiation Therapy and Radiation Oncology, University Hospital of Münster, Münster, Germany.

Giovanni Nano (G)

Operative Unit of Vascular Surgery, IRCCS Policlinico San Donato, San Donato Milanese, Italy; Department of Biomedical Sciences for Health University of Milan, Milan, Italy.

Alexey Tomilin (A)

Institute of Cytology, Russian Academy of Science, St-Petersburg, Russia; Institute of Translational Biomedicine, St-Petersburg University, St-Petersburg, Russia.

James Kehler (J)

National Institutes of Health, NIDDK, Laboratory of Cell and Molecular Biology, Bethesda, MD, United States.

Daniela Gerovska (D)

Computational Biology and Systems Biomedicine, Biogipuzkoa Health Research Institute, San Sebastian, Spain.

Daniela Mazzaccaro (D)

Operative Unit of Vascular Surgery, IRCCS Policlinico San Donato, San Donato Milanese, Italy.

Martin Götte (M)

Department of Gynecology, and Obstetrics, University Hospital of Münster, Münster, Germany.

Marcos J Arauzo-Bravo (MJ)

Computational Biology and Systems Biomedicine, Biogipuzkoa Health Research Institute, San Sebastian, Spain; Basque Foundation for Science, IKERBASQUE, Bilbao, Spain; Department of Cell Biology and Histology, Faculty of Medicine and Nursing, University of Basque Country (UPV/EHU), Leioa, Spain.

Salvarani Carlo (S)

Rheumatology Unit, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy; University of Modena and Reggio Emilia, Modena, Italy.

Ileana Zucchi (I)

Institute of Biomedical Technologies, National Research Council, Milan, Italy; Associazione Fondazione Renato Dulbecco, Milan, Italy. Electronic address: ileanazucchi@icloud.com.

Rolland Reinbold (R)

Institute of Biomedical Technologies, National Research Council, Milan, Italy; Associazione Fondazione Renato Dulbecco, Milan, Italy. Electronic address: rolland.reinbold@itb.cnr.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH